About Texas Research Center
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Human Genome Sciences Inc.
4
Genentech, Inc.
3
Bristol-Myers Squibb
2
Hoffmann-La Roche
2
Amgen
1
Clinical Trials at Texas Research Center
During the past decade, Texas Research Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Safety and Efficacy Study of LymphoStat-B (Belimumab) in Subjects With Systemic Lupus Erythematosus (SLE)
2003-10-01
2006-06-01
Completed
449
A Safety and Efficacy Study of LymphoStat-B™ (Monoclonal Anti-BLyS Antibody) in Subjects With Rheumatoid Arthritis (RA)
2003-12-01
2005-12-01
Completed
283
Abatacept in the Treatment and Prevention of Active Systemic Lupus Erythematosus (SLE) Flares in Combination With Prednisone
2005-09-01
2008-11-01
Completed
183
A Study to Evaluate the Safety of Rituximab Retreatment in Subjects With Systemic Lupus Erythematosus
2005-05-10
2008-08-25
Completed
262
A Study to Evaluate the Safety of Rituximab Retreatment in Subjects With Systemic Lupus Erythematosus
2006-06-22
2012-02-29
Terminated
31
A Study of Belimumab in Subjects With Systemic Lupus Erythematosus
2006-12-01
2010-03-01
Completed
819
A Study of Ocrelizumab Compared to Placebo in Patients With Active Rheumatoid Arthritis Who Don't Have a Response to Anti-TNF-α Therapy (SCRIPT)
2007-05-15
2018-05-14
Terminated
836
A Study of the Effect of Tocilizumab on Markers of Atherogenic Risk in Patients With Moderate to Severe Rheumatoid Arthritis
2007-10-31
2011-01-31
Completed
132
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Texas Research Center" #1 sponsor was "Human Genome Sciences Inc." with 4 trials, followed by "Genentech, Inc." with 3 trials
sponsored, "Bristol-Myers Squibb" with 2 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored and "Amgen"
with 2 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Texas Research Center"
#1 collaborator was "GlaxoSmithKline" with 1 trials as a collaborator and "Roche Pharma AG" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Texas Research Center
According to Clinical.Site data, the most researched conditions in "Texas Research Center" are
"Rheumatoid Arthritis" (4 trials), "Lupus Erythematosus, Systemic" (3 trials), "Systemic Lupus Erythematosus" (2 trials), "Arthritis, Rheumatoid" (1 trials) and "Psoriatic Arthritis" (1 trials). Many other conditions were trialed in "Texas Research Center" in a lesser frequency.
Clinical Trials Intervention Types at Texas Research Center
Most popular intervention types in "Texas Research Center" are "Drug" (12 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (8 trials), "Belimumab 1 mg/kg" (3 trials), "Belimumab 10 mg/kg" (3 trials), "Methotrexate" (3 trials) and "Acetaminophen" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Texas Research Center
The vast majority of trials in "Texas Research Center" are
12 trials for "All" genders.
Clinical Trials Status at Texas Research Center
Currently, there are NaN active trials in "Texas Research Center".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 9 completed trials in Texas Research Center,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Texas Research Center, 0 "Phase 1"
clinical trials were conducted, 5 "Phase 2" clinical
trials and 8 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".